News stories about HCA Healthcare (NYSE:HCA) have trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. HCA Healthcare earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.4461196867544 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

HCA Healthcare (NYSE HCA) traded down $0.15 during midday trading on Monday, reaching $92.86. The company’s stock had a trading volume of 1,843,974 shares, compared to its average volume of 2,191,650. The firm has a market cap of $33,380.00, a P/E ratio of 13.21, a P/E/G ratio of 1.22 and a beta of 0.55. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. HCA Healthcare has a 52 week low of $71.18 and a 52 week high of $93.39.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting the consensus estimate of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. The business’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. sell-side analysts anticipate that HCA Healthcare will post 6.56 EPS for the current fiscal year.

A number of brokerages recently issued reports on HCA. Argus set a $97.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a research report on Wednesday, January 10th. Zacks Investment Research downgraded HCA Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. KeyCorp reissued an “overweight” rating and set a $90.00 price objective (down from $95.00) on shares of HCA Healthcare in a research report on Thursday, October 19th. UBS Group downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 18th. Finally, Bank of America cut their price objective on HCA Healthcare from $92.00 to $86.00 and set a “neutral” rating for the company in a research report on Thursday, October 19th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $88.32.

In other news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $86.63, for a total value of $207,912.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of HCA Healthcare stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the transaction, the insider now owns 12,476 shares of the company’s stock, valued at approximately $973,128. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,550 shares of company stock valued at $1,606,172. 2.90% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with's FREE daily email newsletter.